Healthcare provider profile · identity verified

Brian E. Dolnick, DO

Internal Medicine · MODESTO, CA · NPI 1003994914

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	506	84
Atorvastatin Calcium	Atorvastatin Calcium	452	155
Amlodipine Besylate	Amlodipine Besylate	324	107
Lisinopril	Lisinopril	292	100
Levothyroxine Sodium	Levothyroxine Sodium	253	81
Losartan Potassium	Losartan Potassium	236	85
Hydrochlorothiazide	Hydrochlorothiazide	191	64
Trazodone Hcl	Trazodone Hcl	177	46
Tamsulosin Hcl	Tamsulosin Hcl	163	46
Atenolol	Atenolol	153	52
Fluticasone Propionate	Fluticasone Propionate	139	67
Pantoprazole Sodium	Pantoprazole Sodium	137	49
Albuterol Sulfate Hfa	Albuterol Sulfate	136	70
Metformin Hcl	Metformin Hcl	107	37
Rosuvastatin Calcium	Rosuvastatin Calcium	104	35
Metoprolol Tartrate	Metoprolol Tartrate	102	41
Montelukast Sodium	Montelukast Sodium	100	28
Ibuprofen	Ibuprofen	96	39
Furosemide	Furosemide	94	32
Alvesco	Ciclesonide	88	41
Terazosin Hcl	Terazosin Hcl	87	26
Glipizide	Glipizide	84	30
Alprazolam	Alprazolam	83	18
Metoprolol Succinate	Metoprolol Succinate	83	31
Allopurinol	Allopurinol	79	26
Simvastatin	Simvastatin	79	24
Omeprazole	Omeprazole	76	31
Nabumetone	Nabumetone	75	33
Tramadol Hcl	Tramadol Hcl	75	15
Famotidine	Famotidine	73	29
Metformin Hcl Er	Metformin Hcl	73	28
Tizanidine Hcl	Tizanidine Hcl	72	35
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	71	25
Doxycycline Monohydrate	Doxycycline Monohydrate	64	45
Humulin N	Insulin Nph Human Isophane	64	19
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	60	46
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	60	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	60	29
Gabapentin	Gabapentin	58	27
Meloxicam	Meloxicam	57	19
Finasteride	Finasteride	52	17
Hydralazine Hcl	Hydralazine Hcl	50	19
Buspirone Hcl	Buspirone Hcl	48	14
Duloxetine Hcl	Duloxetine Hcl	48	18
Potassium Chloride	Potassium Chloride	42	19
Jardiance	Empagliflozin	41	15
Morphine Sulfate Er	Morphine Sulfate	41	suppressed
Lovastatin	Lovastatin	40	14
Ciprofloxacin Hcl	Ciprofloxacin Hcl	37	29
Alendronate Sodium	Alendronate Sodium	36	15
Carvedilol	Carvedilol	36	12
Ciclopirox	Ciclopirox	33	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	33	14
Baclofen	Baclofen	31	suppressed
Cephalexin	Cephalexin	31	27
Hydrocortisone	Hydrocortisone	31	11
Pravastatin Sodium	Pravastatin Sodium	30	11
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	29	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	29	11
Mupirocin	Mupirocin	29	15
Ozempic	Semaglutide	29	12
Clonazepam	Clonazepam	28	suppressed
Clopidogrel	Clopidogrel Bisulfate	28	suppressed
Humulin R	Insulin Regular, Human	28	suppressed
Trospium Chloride	Trospium Chloride	28	12
Venlafaxine Hcl Er	Venlafaxine Hcl	28	suppressed
Warfarin Sodium	Warfarin Sodium	28	suppressed
Azelastine Hcl	Azelastine Hcl	27	suppressed
Fluocinonide	Fluocinonide	27	15
Dicyclomine Hcl	Dicyclomine Hcl	26	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	26	suppressed
Ondansetron Hcl	Ondansetron Hcl	26	suppressed
Citalopram Hbr	Citalopram Hydrobromide	25	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	25	11
Spiriva Respimat	Tiotropium Bromide	25	suppressed
Temazepam	Temazepam	25	suppressed
Bisoprolol Fumarate	Bisoprolol Fumarate	24	suppressed
Chlorthalidone	Chlorthalidone	24	suppressed
Oxycodone Hcl	Oxycodone Hcl	24	suppressed
Nystatin	Nystatin	23	12
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	22	suppressed
Lansoprazole	Lansoprazole	22	suppressed
Ropinirole Hcl	Ropinirole Hcl	22	suppressed
Fenofibrate	Fenofibrate	20	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	20	suppressed
Acyclovir	Acyclovir	19	suppressed
Adacel Tdap	Diph,pertuss(Acell),tet Vac/Pf	19	19
Etodolac	Etodolac	19	suppressed
Propranolol Hcl	Propranolol Hcl	19	suppressed
Sertraline Hcl	Sertraline Hcl	19	suppressed
Azithromycin	Azithromycin	17	17
Ezetimibe	Ezetimibe	17	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	17	suppressed
Metronidazole	Metronidazole	17	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	17	suppressed
Verapamil Er	Verapamil Hcl	17	suppressed
Ondansetron Odt	Ondansetron	16	suppressed
Prednisone	Prednisone	16	suppressed
Colchicine	Colchicine	15	suppressed
Fluconazole	Fluconazole	15	11
Lactulose	Lactulose	15	suppressed
Nitroglycerin	Nitroglycerin	15	13
Pioglitazone Hcl	Pioglitazone Hcl	15	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	15	11
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	15	suppressed
Breyna	Budesonide/Formoterol Fumarate	14	suppressed
Neomycin-Polymyxin-Dexameth	Neomycin/Polymyxin B/Dexametha	14	suppressed
Nystatin-Triamcinolone	Nystatin/Triamcinolone Acet	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Veo Insulin Syringe	Syringe And Needle,insulin,1ml	14	suppressed
Fluorouracil	Fluorouracil	13	13
Glipizide Er	Glipizide	13	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	13	12
Ofloxacin	Ofloxacin	13	11
Sulindac	Sulindac	13	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	13	suppressed
Bupropion Xl	Bupropion Hcl	12	suppressed
Clonidine Hcl	Clonidine Hcl	12	suppressed
Glimepiride	Glimepiride	12	suppressed
Lubiprostone	Lubiprostone	12	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	11	suppressed
Bupropion Hcl Sr	Bupropion Hcl	11	suppressed
Cartia Xt	Diltiazem Hcl	11	suppressed
Clobetasol Propionate	Clobetasol Propionate	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Cromolyn Sodium	Cromolyn Sodium	11	suppressed
Hydromorphone Hcl	Hydromorphone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error